These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31932114)

  • 1. Usefulness of Left Ventricular Assist Device in the Recovery of Severe Amphetamine-Associated Dilated Cardiomyopathy.
    Soucy-Giguère MC; Cinq-Mars A; Charbonneau É; Voisine P; Beaudoin J; Dubois M; Sénéchal M
    Can J Cardiol; 2020 Feb; 36(2):317.e5-317.e7. PubMed ID: 31932114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heavy Burden of Toxic Dilated Cardiomyopathy Among Young Adults: A Retrospective Study and Review of the Literature.
    Cinq-Mars A; Massot M; Belzile D; Turgeon PY; Dubois-Sénéchal SM; Laliberté C; Komlosy MÈ; Leblanc MH; Bergeron S; O'Connor K; Morin J; Bourgault C; Bernier M; Beaudoin J; Radermaker S; Laflamme M; Charbonneau E; Sénéchal M
    Can J Cardiol; 2022 Jan; 38(1):49-58. PubMed ID: 34774720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal amphetamine-associated cardiotoxicity and its medicolegal implications.
    Jacobs W
    Am J Forensic Med Pathol; 2006 Jun; 27(2):156-60. PubMed ID: 16738435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study.
    Birks EJ; George RS; Hedger M; Bahrami T; Wilton P; Bowles CT; Webb C; Bougard R; Amrani M; Yacoub MH; Dreyfus G; Khaghani A
    Circulation; 2011 Feb; 123(4):381-90. PubMed ID: 21242487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midterm follow-up of patients who underwent removal of a left ventricular assist device after cardiac recovery from end-stage dilated cardiomyopathy.
    Hetzer R; Müller JH; Weng YG; Loebe M; Wallukat G
    J Thorac Cardiovasc Surg; 2000 Nov; 120(5):843-53. PubMed ID: 11044309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Temporary mechanical left heart support. Recovery of heart function in patients with end-stage idiopathic dilated cardiomyopathy].
    Müller J; Wallukat G; Weng YG; Dandel M; Spiegelsberger S; Semrau S; Brandes K; Bieda H; Hummel M; Loebe M; Meyer R; Hetzer R
    Herz; 1997 Oct; 22(5):227-36. PubMed ID: 9441154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocompetent cells in durable ventricular assist device-implanted non-ischaemic dilated cardiomyopathy.
    Koga-Ikuta A; Fukushima S; Ishibashi-Ueda H; Tadokoro N; Kakuta T; Watanabe T; Fukushima N; Suzuki K; Fukui T; Fujita T
    Gen Thorac Cardiovasc Surg; 2022 Aug; 70(8):685-693. PubMed ID: 35229229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful mechanical circulatory support for more than two years with a left ventricular assist device in a patient with dilated cardiomyopathy.
    Loebe M; Weng Y; Müller J; Dandel M; Halfmann R; Spiegelsberger S; Hetzer R
    J Heart Lung Transplant; 1997 Nov; 16(11):1176-9. PubMed ID: 9402519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular reconditioning and pump explantation in patients supported by continuous-flow left ventricular assist devices.
    Frazier OH; Baldwin AC; Demirozu ZT; Segura AM; Hernandez R; Taegtmeyer H; Mallidi H; Cohn WE
    J Heart Lung Transplant; 2015 Jun; 34(6):766-72. PubMed ID: 25447571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Who would be a candidate for bridge to recovery during prolonged mechanical left ventricular support in idiopathic dilated cardiomyopathy?
    Matsumiya G; Monta O; Fukushima N; Sawa Y; Funatsu T; Toda K; Matsuda H
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):699-704. PubMed ID: 16153916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripartum cardiomyopathy with cardiogenic shock: recovery after prolactin inhibition and mechanical support.
    Emmert MY; Prêtre R; Ruschitzka F; Krähenmann F; Falk V; Wilhelm MJ
    Ann Thorac Surg; 2011 Jan; 91(1):274-6. PubMed ID: 21172530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful bridge to resynchronization therapy with a left ventricular assist system in a patient with idiopathic dilated cardiomyopathy.
    Nishimura M; Ogiwara M; Ishikawa M; Imanaka K; Okamura N; Kato M; Asano H; Katogi T; Kohmoto O; Matsumoto K; Nishimura S; Kyo S
    J Artif Organs; 2005; 8(3):210-3. PubMed ID: 16235039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct epicardial assist device using artificial rubber muscle in a swine model of pediatric dilated cardiomyopathy.
    Saito Y; Suzuki Y; Kondo N; Kowatari R; Daitoku K; Minakawa M; Fukuda I
    Int J Artif Organs; 2015 Nov; 38(11):588-94. PubMed ID: 26659480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Congestive cardiomyopathy in addiction to clobenzorex, an anorexigenic drug].
    Cornaert P; Camblin J; Graux P; Anaye B; Dutoit A; Croccel L
    Arch Mal Coeur Vaiss; 1986 Apr; 79(4):515-8. PubMed ID: 3090971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid Exclusion of HeartMate ІІ Left Ventricular Assist Device After Bridge to Recovery.
    El-Sayed Ahmed MM; Jones MB; Kanter JP; Boyce S; Jonas RA; Scheel J; Sinha P
    Ann Thorac Surg; 2016 Jun; 101(6):e193-4. PubMed ID: 27211979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic and physiologic changes during support with an implantable left ventricular assist device.
    McCarthy PM; Savage RM; Fraser CD; Vargo R; James KB; Goormastic M; Hobbs RE
    J Thorac Cardiovasc Surg; 1995 Mar; 109(3):409-17; discussion 417-8. PubMed ID: 7877301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of cardiac stability after weaning from left ventricular assist devices in patients with idiopathic dilated cardiomyopathy.
    Dandel M; Weng Y; Siniawski H; Potapov E; Drews T; Lehmkuhl HB; Knosalla C; Hetzer R
    Circulation; 2008 Sep; 118(14 Suppl):S94-105. PubMed ID: 18824777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired von Willebrand syndrome after exchange of the HeartMate XVE to the HeartMate II ventricular assist device.
    Malehsa D; Meyer AL; Bara C; Strüber M
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1091-3. PubMed ID: 19303790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure to Amphetamines Leads to Development of Amphetamine Type Stimulants Associated Cardiomyopathy (ATSAC).
    Jafari Giv M
    Cardiovasc Toxicol; 2017 Jan; 17(1):13-24. PubMed ID: 27663745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-controlled conditioning for left ventricular assist device-induced myocardial recovery.
    Healy AH; Koliopoulou A; Drakos SG; McKellar SH; Stehlik J; Selzman CH
    Ann Thorac Surg; 2015 May; 99(5):1794-6. PubMed ID: 25952209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.